# Enhancing the A in SAFE for Trachoma

> **NCT05634759** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 34630 (actual)

## Conditions studied

- Trachoma

## Interventions

- **DRUG:** Azithromycin for Routine Community-wide MDA
- **DRUG:** Two Additional Rounds of Azithromycin for Children
- **DRUG:** Azithromycin for Second Community-wide MDA

## Key facts

- **NCT ID:** NCT05634759
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-04
- **Primary completion:** 2023-08-05
- **Final completion:** 2023-08-05
- **Target enrollment:** 34630 (ACTUAL)
- **Last updated:** 2024-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05634759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05634759, "Enhancing the A in SAFE for Trachoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05634759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*